title: What is the appropriate use of palliative docetaxel in castration-resistant prostate cancer?
authors.affiliation: Division of Clinical Cancer Epidemiology, Institute of Clinical Sciences, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital , Gothenburg.
authors.forename: Gunnar
authors.initials: G
authors.lastname: Steineck
authors.forename: Bengt
authors.initials: B
authors.lastname: Glimelius
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*